SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Maternal-Fetal Medicine Consultation — Mumtaz Mahal — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMumtaz Mahal
Date of birth1593-04-27
IdentifiersMRN HR-RE006-SYN-TD; SSN (made up) 000-06-7184
Document date1631-02-03
AuthorAdaeze Montgomery-Rahimi, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Fourteenth pregnancy at 37, at 13 weeks 2 days by today's scan, conceived about five and a half months after her last birth, with iron deficiency anemia. Please advise on surveillance, anemia treatment, placental assessment, the timing and place of birth, and planning to prevent postpartum hemorrhage. [S]

Urgency: Routine, within four weeks. [S]

Questions for the consultant:

History of Present Illness

Mumtaz Mahal is seen at the request of Dr. Qureshi-Lindholm at 17 weeks 2 days. She has had thirteen vaginal births, all by her account at or near term, with labors that were often short, and no cesarean, uterine surgery, or blood transfusion; she does not know of heavy bleeding after any birth. One baby died soon after birth, and five other children died in infancy or early childhood. This pregnancy began about five and a half months after her last birth. She has taken about half of her oral iron doses because of nausea and constipation and remains tired. She has no bleeding, pain, or urinary symptoms and has felt the first movements. She travels often with her family and expects to travel again in the spring. She wants clear plans and prefers women clinicians. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Folic acid 0.4 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1631-01-06activeS
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other dayOne tablet every other morning with water or orange juice, apart from tea and calciumOral route1631-01-06 to 1631-02-03completedS
Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtimeOne tablet by mouth at bedtime until deliveryOral route1631-01-06activeS
Ferric carboxymaltose 750 mg in 250 mL 0.9% sodium chloride, intravenous infusion over 15 minutes (first of two doses)Single infusion; two doses in total, four weeks apartIntravenous route1631-02-03 to 1631-02-03completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Fourteenth pregnancy at 37 (gravida 14, para 13), single live intrauterine pregnancy dated by ultrasound at 13 weeks 2 days; estimated due date July 12activeconfirmed O09.529S — Synthetic modern prenatal care anchored to her documented fourteenth pregnancy; the dates are synthetic.
Grand multiparity: thirteen previous vaginal births, no cesarean or other uterine surgery; seven living childrenactiveconfirmed O09.40S — Synthetic modern problem anchored to her documented thirteen earlier births.
Short interpregnancy interval: conception about five and a half months after her last birthactiveconfirmed O09.899S — Synthetic modern problem anchored to the documented fourteen months between her last two births.
Iron deficiency anemia in pregnancy: hemoglobin 10.1 g/dL, MCV 76 fL, ferritin 9 ng/mLactiveconfirmed O99.019S — Synthetic finding; repeated pregnancies close together deplete iron. It echoes no documented diagnosis.

Physical Exam

Vital signs recorded on 1631-02-03; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell; pale conjunctivae
AbdomenUterus consistent with 17 weeks; non-tender; no scars
FetalFetal heart 152 per minute

Results

DateMeasureValueUnitReference rangeFlagProvenance
1631-02-03Hemoglobin [Mass/volume] in Blood10.3g/dL10.5-15 g/dLLowS
1631-02-03Ferritin [Mass/volume] in Serum or Plasma12ng/mL30-150 ng/mLLowS

Assessment

Data reviewed: The dating and nuchal translucency scan; cell-free DNA (low risk); blood group O RhD positive with a negative antibody screen; rubella immune; hepatitis B, HIV, syphilis, and hepatitis C negative; urine culture no growth; hemoglobin electrophoresis normal; hemoglobin 10.1 g/dL with ferritin 9 ng/mL at intake and 10.3 g/dL with ferritin 12 ng/mL today; hemoglobin A1c 5.4 percent; today's vital signs (blood pressure 106/64 mmHg, weight 59.8 kg). [S]

Plan of Treatment